Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma
Phase 2
Completed
- Conditions
- Sarcoma, Soft Tissue
- Registration Number
- NCT00061659
- Lead Sponsor
- Abbott
- Brief Summary
The primary objective of this study is to assess the safety and effectiveness of ABT-510 in subjects with locally advanced or metastatic soft tissue sarcoma.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 88
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Progression free survival One year
- Secondary Outcome Measures
Name Time Method Response rate One year Overall survival One year Performance status One year
Trial Locations
- Locations (5)
Virginia G. Piper Cancer Center
🇺🇸Scottsdale, Arizona, United States
Arizona Cancer Center
🇺🇸Tucson, Arizona, United States
Center for Sarcoma and Bone Oncology Dana-Farber Cancer Institute
🇺🇸Boston, Massachusetts, United States
University of Michigan
🇺🇸Ann Arbor, Michigan, United States
Cancer Therapy and Research Center
🇺🇸San Antonio, Texas, United States
Virginia G. Piper Cancer Center🇺🇸Scottsdale, Arizona, United States